Atlas Trials

A Study Assessing the Efficacy and Safety of CBP-307 in Subjects With Moderate to Severe Ulcerative Colitis (UC)

Clinical trial NCT04700449 · COMPLETED

Trial details

NCT number
NCT04700449
Sponsor
Connect Biopharm LLC
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Ulcerative Colitis
Start date
2019-02-27
Primary completion
2022-02-23
Enrollment
145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.